TickerFacts.

Cannabis Bioscience International Holdings, Inc. (CBIH): Cost of Revenue

Annual figures by period end, from SEC filings.

$40.1K
Year ended 2025-05-31
$26.2K
Trailing 12 months to 2026-02-28
$93.5K2023-05-31: $93.5K2024-05-31: $45.6K2025-05-31: $40.1K$40.1K
2023-05-31 Cost of Revenue (USD) 2025-05-31
Period endedCost of RevenueChange YoYSource filing
2025-05-31$40.1K-12.0%2025-09-22, From 2024-06-01
2024-05-31$45.6K-51.2%2025-09-22, From 2023-06-01
2023-05-31$93.5Kn/a2024-09-16, From 2022-06-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31$40.1K-12.0%
OneMedNet Corp (ONMD)2025-12-31$1.86M+101.5%
iSpecimen Inc. (ISPC)2025-12-31$1.90M-64.1%
MaxCyte, Inc. (MXCT)2025-12-31$6.22M-12.4%
Incyte Corp (INCY)2025-12-31$372.13M+19.2%
Icon PLC (ICLR)2024-12-31$5.85B+2.2%
Weed, Inc. (BUDZ)2025-12-31$0n/a
Vitaspring Biomedical Co. Ltd. (VSBC)2026-01-31$0n/a

Compare CBIH, ONMD, ISPC, MXCT side by side · Screen every company in Services-Commercial Physical & Biological Research ↗